Cite
HARVARD Citation
Gold, R. et al. (2020). Safety and efficacy of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: 9 years' follow-up of DEFINE, CONFIRM, and ENDORSE. Therapeutic advances in neurological disorders. p. . [Online].